Defensin Peptides vs ZO Skin Health®: Retinol Systems vs Regenerative Skincare
ZO Skin Health is one of the most comprehensive retinol-based systems in medical skincare. DefenAge takes a fundamentally different approach — fewer products, a defined regenerative mechanism, and published clinical evidence for a specific biological pathway that retinol systems do not address. For patients seeking a retinol alternative with clinical evidence, that distinction matters.
ZO Skin Health and DefenAge are both used in clinical and medical spa settings, both have published clinical evidence, and both serve patients who want visible anti-aging results. They are not competing for different customers — they are competing with different philosophies about how skin improvement works.
ZO Skin Health is built around a comprehensive system protocol. Dr. Zein Obagi's approach centers on "Getting Skin Ready" — a multi-step daily regimen covering cleansing, exfoliation, retinol-based correction, antioxidant protection, targeted treatment, and sun protection. ZO has published clinical outcome data on specific products. Its system is genuinely comprehensive and has real results across a broad range of skin concerns.
Retinoid-based skincare systems like ZO remain among the most widely studied and clinically used approaches in dermatology, with decades of published research supporting their role in improving visible signs of aging.
DefenAge Age-Repair Defensins® are built around a specific regenerative mechanism. Alpha-Defensin 5 and Beta-Defensin 3 are patented bioidentical peptides with published peer-reviewed mechanisms — stem cell support in the epidermis and fibroblast signaling in the dermis. Four published peer-reviewed clinical studies document visible improvements. The approach is narrower in category scope but deeper in its specific biological action.
The meaningful question is not which system is better overall. It is whether a comprehensive retinol-centered protocol addresses the same biological goals as a regenerative signaling technology — and whether those two approaches might serve the same patient in complementary rather than competing roles.
For a broader look at how defensin peptides compare to retinol as a category — not just as a brand system — see Defensin Peptides vs Retinol.
ZO Skin Health covers a broad range of skin concerns through a multi-product retinol-centered protocol with published clinical outcome data. DefenAge has four published peer-reviewed studies — including a multi-center, double-blind, vehicle-controlled trial (Taub et al, JDD 2018) — documenting statistically significant visible improvement through a defined regenerative peptide mechanism. The two approaches address different biological goals and are not direct substitutes for each other.
The most useful question for a consumer is: does a retinol-based correction protocol address the same biological pathway as a regenerative signaling technology? The published evidence suggests these represent different and potentially complementary approaches — not the same approach at different price points.
Two patented, lab-synthesized bioidentical peptides — Alpha-Defensin 5 and Beta-Defensin 3. Defined regenerative mechanisms published in peer-reviewed journals. Four published clinical studies. Fully synthetic, vegan. Exclusive to DefenAge — no other brand can formulate with these molecules.
A comprehensive multi-product medical skincare system founded by Dr. Zein Obagi. Core active ingredients include retinol (0.25–1%), branded complexes (ZO-RRS2®, ZPOLY™, ZCORE™), plant-based extracts, peptides, acids, and antioxidants. 20+ products across cleansing, prevention, correction, treatment, and protection categories.
Where ZO's System Excels — and Where the Biological Gap Is
Reviewing the complete ZO portfolio against a specific biological question reveals a consistent gap in the published research.
| ZO System Layer | Representative Products | Biology Addressed | Regenerative Signaling? |
|---|---|---|---|
| Getting Skin Ready® | Cleansers, Exfoliating Polish, Complexion Renewal Pads | Surface cleansing, exfoliation, pH normalization | No |
| Prevent + Correct | Daily Power Defense ($190), Retinol Skin Brightener, Illuminating AOX | Antioxidant protection, retinol cell turnover, brightening | No |
| Targeted Treatment | Growth Factor Serum ($180), Firming Serum ($265), Rozatrol | Plant-derived growth factor support, barrier support, redness reduction | No — plant stem cell extracts and Syn-Ake peptide, not defined regenerative signals |
| Post-Procedure | Post Procedure Recovery Kit | Wound management — soothing, astringent, hydration | No — wound care support, not regenerative signaling |
| Protect | Sunscreens SPF 50 | UV/HEV/IR-A protection | No |
| The gap → | DefenAge defensin peptides | Published regenerative signaling — epidermal and dermal | Yes — patented bioidentical peptides with peer-reviewed mechanisms |
This is not a criticism of ZO's system. It is an observation about biological categories. Retinol accelerates the rate at which existing cells reach the surface. Antioxidants protect against oxidative damage. Plant extracts provide barrier and anti-inflammatory support. These are all valuable and well-evidenced approaches. None of them addresses the same biological pathway as published defensin research — which documents visible skin improvements through a specific regenerative signaling mechanism in peer-reviewed studies.
The Published Clinical Evidence
Multi-center, double-blind, vehicle-controlled trial
Participants using the DefenAge defensin regimen demonstrated statistically significant visible improvement in tone, texture, firmness, lines, and overall appearance versus vehicle control. Evaluation included clinical grading, histopathology, immunohistochemistry, photography, and ultrasound.
JDD 2018;17(4):426–441. PMID: 29601620
Periocular wrinkles — independent replication
An independent follow-up trial in which participants demonstrated significant visible improvement in periocular wrinkles with the enhanced-concentration defensin BioSerum versus control.
JDD 2023;22(9):874–880. PMID: 37683059
Eye cream trial — periocular rhytids
Published trial of the DefenAge 3D Eye Radiance Cream documenting visible improvement in periocular wrinkles and skin quality in study participants.
J Cosmet Dermatol. 2020;19(8):2000–2005. doi: 10.1111/jocd.13424. PMID: 32614135
Body cream trial — skin composition
Published trial of the DefenAge 10 Luxe Hand and Body Cream documenting visible improvement in skin composition and quality — extending defensin clinical evidence to body skin.
J Cosmet Dermatol. 2023;22(2):620–627. doi: 10.1111/jocd.15118. PMID: 35621235
ZO Skin Health publishes clinical outcome data for specific products — including before/after studies showing visible improvement with the Growth Factor Serum (93% improvement in fine lines at 12 weeks in one published study) and pigmentation protocols in the Journal of Drugs in Dermatology. ZO's clinical evidence is real and its retinol-based outcomes are well-supported by the extensive published retinol literature. The distinction is that ZO's published evidence demonstrates outcomes from retinol and supporting ingredients — a different biological mechanism than the regenerative signaling pathway documented in DefenAge's peer-reviewed trials.
Defensins are also compared to other professional formulation platforms, including SkinBetter Science® and SkinCeuticals® antioxidant science — each representing a different approach to visible skin renewal.
Key Differences at a Glance
| Category | DefenAge Age-Repair Defensins® | ZO Skin Health |
|---|---|---|
| Core approach | Defined regenerative signaling — two patented peptides with published biological mechanisms | Comprehensive multi-product protocol — retinol-centered correction supported by exfoliation, antioxidants, and targeted treatments |
| Retinoid content | Not a retinoid — works through a different biological pathway entirely; well tolerated in study participants including those who had not completed retinoid regimens | Retinol is the primary active ingredient — available in multiple concentrations (0.25% to 1%); retinol-related tolerability considerations apply |
| Product count | Focused product line — one hero product delivers the core regenerative mechanism | 20+ products; full protocol requires 5–8+ daily products layered in specific order |
| Published clinical trials | Four published peer-reviewed studies across face, eyes, body, and post-procedure contexts in three journals | Published clinical outcome data on specific products; extensive retinol literature supports mechanism |
| Study methodology | Multi-center, double-blind, vehicle-controlled (Taub 2018) with histopathology and ultrasound | Published clinical studies with outcome data; retinol mechanism supported by decades of published research |
| Ingredient exclusivity | Patents on the molecules themselves — no other brand can source Alpha-Defensin 5 or Beta-Defensin 3 for topical use | Trademark protection on branded complex names (ZO-RRS2®, ZPOLY™, ZCORE™) — underlying ingredients including retinol, plant extracts, and generic peptides are widely available |
| Ingredient origin | Fully synthetic, vegan, no human- or animal-derived material | Synthetic and plant-derived ingredients; no human-derived material |
| Hero product price | $198 (8-in-1 BioSerum) | Individual products $47–$265; full ZO protocol typically $500–$800+ per year |
Four Meaningful Differences Worth Understanding
A biological category ZO's system does not address
Reviewing the complete ZO portfolio — cleansing, retinol correction, antioxidant protection, targeted treatment, post-procedure wound management, and sun protection — reveals one consistent gap: no product in the system is documented in peer-reviewed research to support the specific regenerative pathway addressed by defensin peptides. ZO addresses what retinol, acids, and antioxidants can address — which is genuinely valuable. What it does not address is the documented age-related decline in defensin levels and the published regenerative signaling mechanism those peptides support.
A retinoid alternative with published evidence
ZO's core mechanism is retinol-based — accelerating cell turnover through vitamin A receptor activation. For the significant portion of patients who cannot tolerate retinol at any concentration — those with rosacea, sensitive skin, or a compromised barrier — ZO's primary mechanism is inaccessible. In the Taub et al 2018 trial, the defensin regimen was well tolerated in study participants including those who had not completed retinoid regimens, while demonstrating statistically significant visible improvement. DefenAge serves patients that retinol-centered systems cannot.
Defined molecules vs trademarked ingredient names
ZO's branded complex names — ZO-RRS2®, ZPOLY™, ZCORE™ — are trademark-protected marketing names. The underlying ingredients are commercially available: prickly pear extract, kelp, plant polysaccharides, generic peptides. A trademark protects a name; a patent protects a molecule. DefenAge's patents cover Alpha-Defensin 5 and Beta-Defensin 3 themselves — the molecules cannot be sourced or replicated by any other brand regardless of how they are named or formulated.
Simplicity and compliance
ZO's comprehensiveness is also its compliance challenge. A full ZO protocol requires 5–8 daily products layered in sequence — each additional step is a potential point of non-adherence, particularly for post-procedure patients who are already managing recovery. DefenAge's defensin technology delivers its published regenerative mechanism in a single application that layers with whatever else a patient is already using. For patients who struggle with complex multi-step routines, this is a practical clinical advantage.
Are These Complementary or Competing?
This is genuinely worth addressing directly. For many patients, ZO and DefenAge may not be an either/or choice.
ZO's system addresses surface preparation, retinol-based correction, antioxidant protection, and sun defense — all of which remain valid and valuable regardless of what regenerative technology a patient uses. DefenAge adds a specific biological dimension that retinol, acids, and antioxidants do not address in published research.
DefenAge is designed to layer with existing routines, including retinol-based products. The biological pathways are different enough that the two approaches can complement rather than duplicate each other. A patient on a ZO regimen who wants to add published regenerative support is a natural candidate for DefenAge — not a reason to abandon the ZO protocol entirely.
DefenAge is the stronger choice if:
- You want a retinoid alternative with published clinical trial evidence
- You have sensitive skin, rosacea, or cannot tolerate retinol at any concentration
- You want a focused approach rather than a multi-step protocol
- You want patented molecules — not trademarked names for available ingredients
- You want four published peer-reviewed studies across multiple product categories
- You want to add a documented regenerative dimension to an existing skincare routine
ZO Skin Health may appeal to you if:
- You want a comprehensive protocol addressing multiple skin concerns simultaneously
- You tolerate retinol well and want progressive retinol-based correction
- You are managing specific concerns — pigmentation, acne, rosacea — that ZO targets directly
- You prefer a system with a long-established clinical track record and wide provider network
ZO Skin Health is a legitimate, well-established brand with real published clinical evidence and a comprehensive approach to skin health management. Its retinol-based protocols have a long track record and serve patients across a broad range of concerns. It is a genuinely strong system for what it does.
What ZO's system does not address — in any of its 20+ products — is the specific regenerative signaling pathway documented in DefenAge's four published peer-reviewed clinical studies. That is not a weakness of ZO's formulation quality. It is simply a different biological category that retinol, acids, plant extracts, and antioxidants do not cover in the published evidence.
For patients who want retinol-based comprehensive skin management, ZO is a strong system. For patients who want a documented regenerative signaling approach — or who cannot tolerate retinoids and need an evidence-backed alternative — DefenAge addresses biological goals that ZO's protocol does not.
What Dermatologists Have Said About Defensin Technology
"The science is remarkable. For patients who previously couldn't tolerate retinoids, the visible results I've seen with defensin technology have been genuinely impressive."
Amy Taub, MD Lead author, Taub et al JDD 2018; co-investigator, Hartman et al JDD 2023
"For patients with sensitive skin or rosacea who need effective anti-aging without retinol irritation, this is the alternative I reach for. It delivers visible results without the trade-offs."
Melda Isaac, MD Board-Certified Dermatologist, Washington DC
"Defensins represent a new era in skin rejuvenation. The approach is genuinely distinct from growth factors, retinoids, and standard peptide categories — it belongs in its own class."
Gregory Keller, MD Principal Investigator, Taub et al 2018; Berens et al 2020; Eggerstedt et al 2023
Frequently Asked Questions
Is DefenAge the same as ZO Skin Health?
No — they represent different approaches to skin improvement with different core mechanisms. ZO is a comprehensive multi-product protocol centered on retinol-based correction, exfoliation, antioxidant protection, and targeted treatment. DefenAge uses two patented bioidentical peptides with published peer-reviewed mechanisms in a focused product line. Both have published clinical evidence; they address different biological goals and are not direct substitutes for each other.
Can I use DefenAge if I am already on a ZO protocol?
Yes — DefenAge is designed to layer with existing skincare routines, including retinol-based products. Because defensin peptides work through a different biological pathway than retinol, they can complement rather than duplicate ZO's mechanism. A patient already using a ZO protocol who wants to add a documented regenerative dimension to their routine can do so without needing to discontinue their ZO regimen. Specific layering decisions should be guided by a dermatologist or skincare provider.
Does ZO have published clinical evidence?
Yes — ZO publishes clinical outcome data on specific products, including studies on its Growth Factor Serum and pigmentation protocols in the Journal of Drugs in Dermatology. ZO's retinol mechanism is also supported by decades of published retinol research across the broader scientific literature. DefenAge has four product-specific published peer-reviewed studies across three journals — including a multi-center, double-blind, vehicle-controlled trial. Both brands have real published evidence; the mechanisms, methodologies, and biological categories addressed differ.
Is DefenAge a replacement for retinol?
DefenAge is used by dermatologists as a retinoid alternative for patients who have not completed retinoid regimens. In the Taub et al 2018 trial, the defensin regimen was well tolerated in study participants — including those who had not completed retinoid regimens — while demonstrating statistically significant visible improvement. For patients who tolerate retinol well, DefenAge can serve as a complementary approach addressing a different biological pathway rather than a replacement for retinol-based correction.
What makes ZO's branded ingredient complexes different from DefenAge's patents?
ZO's branded complex names — ZO-RRS2®, ZPOLY™, ZCORE™ — are registered trademarks protecting the names applied to ingredient combinations. The underlying ingredients (plant extracts, polysaccharides, generic peptides) are commercially available from any cosmetic ingredient supplier. DefenAge holds patents on Alpha-Defensin 5 and Beta-Defensin 3 themselves for topical skincare use — the molecules cannot be sourced, formulated, or sold by any other brand. A trademark protects a name; a patent protects a molecule.
How does the cost of DefenAge compare to a full ZO protocol?
DefenAge's 8-in-1 BioSerum is $198. A full ZO protocol covering the standard Getting Skin Ready, Prevent, Correct, and Protect categories typically involves 5–8 products at a combined retail cost of $500–$800 or more per year, depending on which products are included. Individual ZO products range from approximately $47 to $265. DefenAge's focused approach delivers its published regenerative mechanism in a single product at a price point considerably below a full ZO annual protocol.
Explore more comparisons
References & Further Reading
- Taub A, Bucay V, Keller G, Williams J, Mehregan D. "Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen." Journal of Drugs in Dermatology. 2018;17(4):426–441. PMID: 29601620
- Hartman N, Loyal J, Taub A, Fabi S. "Clinical Trial of Alpha and Beta Defensin Skin Care Regimen for Improvement of Periocular Wrinkles." Journal of Drugs in Dermatology. 2023;22(9):874–880. doi: 10.36849/JDD.7184. PMID: 37683059
- Berens AM, Ghazizadeh S. "Effect of defensins-containing eye cream on periocular rhytids and skin quality." Journal of Cosmetic Dermatology. 2020;19(8):2000–2005. doi: 10.1111/jocd.13424. PMID: 32614135
- Eggerstedt M, Torres-Maldonado S, Danielian A, Hwang SHJ, Echanique KA. "Impact of defensins-containing body cream on skin composition." Journal of Cosmetic Dermatology. 2023;22(2):620–627. doi: 10.1111/jocd.15118. PMID: 35621235. PMCID: PMC10087582
- Duncan DI. "Microneedling with Biologicals: Advantages and Limitations." Facial Plastic Surgery Clinics of North America. 2018;26(4):447–454. doi: 10.1016/j.fsc.2018.06.006. PMID: 30213426
- Takahashi M, Umehara Y, Yue H, et al. "The Antimicrobial Peptide Human β-Defensin-3 Accelerates Wound Healing by Promoting Angiogenesis, Cell Migration, and Proliferation Through the FGFR/JAK2/STAT3 Signaling Pathway." Frontiers in Immunology. 2021;12:712781. doi: 10.3389/fimmu.2021.712781
- Shimizu Y, Nakamura K, Kikuchi M, et al. "Lower human defensin 5 in elderly people compared to middle-aged." GeroScience. 2022;44(2):997–1009. PMID: 34105106
- Grove GL, Kligman AM. "Age-associated changes in human epidermal cell renewal." Journal of Gerontology. 1983;38:137–142.
- DefenAge. "Peer-reviewed study confirming effectiveness of defensin-based BioSerum." View study summary
- DefenAge. "Physician testimonials and clinical perspectives." View testimonials
DefenAge products are cosmetic formulations intended to improve the appearance of the skin and are not intended to affect the structure or function of the body. This page is for cosmetic skincare education only and does not constitute medical advice. Physician quotes are sourced from publicly available DefenAge materials and used with permission. ZO Skin Health® and all ZO trademarks are registered trademarks of ZO Skin Health, Inc. — referenced here for comparison purposes only. Age-Repair Defensins® and DefenAge® are trademarks of Progenitor Biologics, LLC. Product prices are approximate and subject to change. Technology comparisons are based on publicly available ingredient information and peer-reviewed literature at time of publication. DefenAge makes no claims regarding the efficacy of competitor technologies.